[1]
L. L. Déo Malaquini, L. F. . Rocha de Souza, L. . Ebani Parada, J. . Gonçalves Grasso, and N. A. . Hala Nunes, “Risk-benefit of tirzepatide, semaglutide, and bariatric surgery in obesity”, Interamerican Journal of Health Sciences, vol. 5, p. 277, Jan. 2025, doi: 10.59471/ijhsc2025277.